MAIA Biotechnology (MAIA) News Today $1.94 -0.26 (-11.82%) (As of 04:45 PM ET) Add Compare Share Share Headlines Stock AnalysisChartEarningsHeadlinesInsider TradesOwnershipShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period MAIA Biotechnology Granted FDA Rare Pediatric Disease Designation for THIO as a Treatment for Pediatric High-Grade GliomasDecember 16 at 9:10 AM | businesswire.comMAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) Director Purchases $46,750.00 in StockDecember 14, 2024 | insidertrades.comStan Smith Acquires 25,000 Shares of MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) StockMAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA - Get Free Report) Director Stan Smith purchased 25,000 shares of the company's stock in a transaction dated Friday, December 13th. The shares were purchased at an average cost of $1.87 per share, for a total transaction of $46,750.00. Following the transaction, the director now directly owns 1,130,060 shares in the company, valued at approximately $2,113,212.20. The trade was a 2.26 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through the SEC website.December 13, 2024 | marketbeat.comMAIA Biotechnology announces $950,000 private placementDecember 10, 2024 | msn.comMAIA Biotechnology Announces Private Placement of Approximately $950,000December 9, 2024 | finance.yahoo.comMAIA Biotechnology, Regeneron expand clinical supply agreementDecember 4, 2024 | markets.businessinsider.comMAIA Biotechnology Announces Expansion of Clinical Supply Agreement with Regeneron for Phase 2 Trial in Non-Small Cell Lung CancerDecember 3, 2024 | businesswire.comDiamond Equity Estimates MAIA Biotechnology Q1 EarningsMAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA - Free Report) - Research analysts at Diamond Equity issued their Q1 2025 earnings estimates for shares of MAIA Biotechnology in a research note issued to investors on Thursday, November 14th. Diamond Equity analyst H. Diamond expects that the company wNovember 18, 2024 | marketbeat.comMAIA Biotechnology Announces Participation by Director Stan Smith, Ph.D. in Recent Private PlacementNovember 8, 2024 | finance.yahoo.comMAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) Director Cristian Luput Buys 22,133 SharesNovember 5, 2024 | insidertrades.comInsider Buying: MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) Director Acquires 22,133 Shares of StockMAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA - Get Free Report) Director Cristian Luput bought 22,133 shares of the firm's stock in a transaction that occurred on Friday, November 1st. The stock was purchased at an average price of $2.51 per share, for a total transaction of $55,553.83. Following the completion of the transaction, the director now directly owns 389,483 shares of the company's stock, valued at $977,602.33. This represents a 0.00 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website.November 4, 2024 | marketbeat.comMAIA Biotechnology prices $2.44M private placementOctober 29, 2024 | msn.comMAIA Biotechnology Announces $2.44 Million Private PlacementOctober 28, 2024 | finance.yahoo.comMAIA Biotechnology (NYSEAMERICAN:MAIA) Shares Down 3.4% - Time to Sell?MAIA Biotechnology (NYSEAMERICAN:MAIA) Shares Down 3.4% - Here's WhyOctober 25, 2024 | marketbeat.comMAIA Biotechnology Announces Poster Presentation of Novel THIO Prodrugs at ENA 2024 Symposium on Molecular Targets and Cancer TherapeuticsOctober 15, 2024 | finance.yahoo.comBurberry's Scarf With Spiber, Corium Biotech Raises Seed Funding, Retail Vets Launch Social Studies ShopOctober 8, 2024 | msn.comMAIA Biotechnology (AMEX:MAIA) Stock, Short Interest ReportOctober 5, 2024 | benzinga.comMAIA Biotechnology (AMEX:MAIA) Stock Quotes, Forecast and News SummaryOctober 5, 2024 | benzinga.comMAIA Biotechnology (NYSEAMERICAN:MAIA) Trading Down 1.1%MAIA Biotechnology (NYSEAMERICAN:MAIA) Trading Down 1.1%October 3, 2024 | marketbeat.comIntel's Breakup Can Generate Significantly More Value For ShareholdersSeptember 25, 2024 | seekingalpha.comMAIA Biotechnology Announces Positive Survival Updates in Phase 2 Study of THIO in Non-Small Cell Lung CancerSeptember 10, 2024 | finance.yahoo.comMAIA Biotechnology to Present New Phase 2 Clinical Trial Data at the H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 4, 2024 | finance.yahoo.comMAIA Biotechnology (NYSEAMERICAN:MAIA) Shares Down 3.9% MAIA Biotechnology (NYSEAMERICAN:MAIA) Shares Down 3.9%September 4, 2024 | marketbeat.comMAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) Short Interest Down 13.9% in AugustMAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA - Get Free Report) saw a significant decline in short interest in the month of August. As of August 15th, there was short interest totalling 669,300 shares, a decline of 13.9% from the July 31st total of 777,300 shares. Approximately 3.4% of the company's shares are sold short. Based on an average daily volume of 279,700 shares, the days-to-cover ratio is presently 2.4 days.September 2, 2024 | marketbeat.comMAIA Biotechnology, Inc. (MAIA) Stock Price, News, Quote & History - Yahoo FinanceAugust 25, 2024 | finance.yahoo.comWhich 10 prescription drugs covered under Medicare are dropping prices in 2026?August 16, 2024 | msn.comSanaz Toossi's play English won a Pulitzer — and now Melbourne Theatre Company brings it to AustraliaAugust 15, 2024 | msn.comGemina Laboratories Ltd. (GLAB.CN)August 2, 2024 | sg.finance.yahoo.comMAIA Biotech Reports Positive Phase 2 Data For THIO With Cemiplimab In Non-Small Cell Lung CancerJuly 23, 2024 | markets.businessinsider.comMAIA Biotechnology Announces New Updates from Phase 2 Trial of Novel Cancer Treatment AgentJuly 23, 2024 | finance.yahoo.comMAIA Biotechnology's Lung Cancer Drug Shows Promising Long-Term Benefits In Advanced PatientsJuly 23, 2024 | benzinga.comMAIA Biotechnology (NYSEAMERICAN:MAIA) Trading 6.1% Higher MAIA Biotechnology (NYSEAMERICAN:MAIA) Stock Price Up 6.1%July 20, 2024 | marketbeat.comMAIA Biotechnology's Telomere Targeting Functionality is Shown Viable by FDA's Approval of a Telomerase Inhibitor Agent TherapyJune 7, 2024 | businesswire.comMAIA Biotechnology Announces Year-to-Date Achievements and Highlights Recent Clinical Progress for Novel Anticancer AgentJune 6, 2024 | businesswire.comMAIA Biotechnology (NYSEAMERICAN:MAIA) Trading Down 14.1%MAIA Biotechnology (NYSEAMERICAN:MAIA) Trading Down 14.1%June 6, 2024 | marketbeat.comMAIA Biotechnology Reveals New Clinical Data Showing THIO's Strong Efficacy in Non-Small Cell Lung CancerJune 4, 2024 | businesswire.comMAIA Biotechnology to Present at the BIO International Convention 2024May 17, 2024 | businesswire.comMAIA Biotechnology Abstract Accepted for Poster Presentation at American Society of Clinical Oncology (ASCO) 2024 Annual MeetingMay 16, 2024 | businesswire.comMAIA Stock Earnings: MAIA Biotechnology Misses EPS for Q1 2024May 15, 2024 | investorplace.comMAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private PlacementApril 30, 2024 | businesswire.comMAIA Biotechnology Shares Hit 52-Week High After Director Stock PurchaseApril 29, 2024 | marketwatch.comMAIA Biotechnology Announces Share Purchase by Director Stan Smith, Ph.D. in Private PlacementApril 29, 2024 | businesswire.comMAIA Biotechnology, Inc. (MAIA)April 28, 2024 | finance.yahoo.comMAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) Director Ngar Yee Louie Acquires 19,665 SharesApril 27, 2024 | insidertrades.comMAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA) Director Acquires $39,919.95 in StockMAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA - Get Free Report) Director Ngar Yee Louie acquired 19,665 shares of the firm's stock in a transaction on Thursday, April 25th. The stock was acquired at an average cost of $2.03 per share, with a total value of $39,919.95. Following the acquisition, the director now owns 1,167,189 shares of the company's stock, valued at $2,369,393.67. The purchase was disclosed in a document filed with the SEC, which is available through this link.April 26, 2024 | marketbeat.comMAIA Biotechnology Announces $1.00 Million Private PlacementApril 23, 2024 | businesswire.comMAIA Biotechnology to Present at Two Investor Conferences in April 2024April 5, 2024 | businesswire.comeFFECTOR shelves tomivosertib in NSCLC following Phase II failureApril 4, 2024 | msn.comMAIA Biotechnology directors buy shares amid development pushMarch 28, 2024 | investing.comMAIA Biotechnology Announces Share Purchases by Directors Cristian Luput and Ramiro GuerreroMarch 28, 2024 | businesswire.com Get MAIA Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for MAIA and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)It’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life-changing for those who are prepared. Why? Because altcoin prices are about to explode. >> Register for the Workshop Now MAIA Media Mentions By Week MAIA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MAIA News Sentiment▼1.420.56▲Average Medical News Sentiment MAIA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MAIA Articles This Week▼41▲MAIA Articles Average Week Get MAIA Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for MAIA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ACRV News ACRS News MOLN News SOPH News BMEA News XBIT News INBX News CRDF News LFVN News SLN News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:MAIA) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | Sponsored“The Last Retirement Stock You’ll Ever Need”We've just released a critical trade alert about a groundbreaking AI investment opportunity. So, I wanted t...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MAIA Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MAIA Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MAIA Stock Alerts